StockNews.com assumed coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS – Free Report) in a research note issued to investors on Sunday morning. The firm issued a sell rating on the stock.
Ayala Pharmaceuticals Stock Performance
ADXS stock opened at $0.03 on Friday. The company has a market capitalization of $1.28 million, a P/E ratio of 0.00 and a beta of 1.81. Ayala Pharmaceuticals has a 52-week low of $0.00 and a 52-week high of $1.49. The company has a fifty day moving average price of $0.04 and a 200-day moving average price of $0.14.
About Ayala Pharmaceuticals
Featured Stories
- Five stocks we like better than Ayala Pharmaceuticals
- Insider Selling Explained: Can it Inform Your Investing Choices?
- Rocket Lab is the Right Stock for the Right Time
- What Investors Need to Know About Upcoming IPOs
- SoundHound AI Will Advance By Triple Digits in 2025: Here’s Why
- Why Are These Companies Considered Blue Chips?
- Celsius Holdings: Big Drop, Big Opportunity? Analysts Say Yes
Receive News & Ratings for Ayala Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ayala Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.